|
Zenith and RVX presenting at Biotech Showcase Jan 11-13 and Zenith AGM Jan 7
|
1
|
Zenith Epigenetics
|
Jan 04, 2016 07:20AM
|
|
Zenith and RVX presenting at Biotech Showcase Jan 11-13 and Zenith AGM Jan 7
|
7
|
Resverlogix Corp.
|
Jan 04, 2016 07:25AM
|
|
Zenith AGM webcast 9/12/2018
|
8
|
Zenith Epigenetics
|
Sep 10, 2018 05:56PM
|
|
Zenith AGM Tuesday 12/12 2:45 MT
|
4
|
Zenith Epigenetics
|
Dec 11, 2017 12:06PM
|
|
Zenith AGM thoughts
|
5
|
Zenith Epigenetics
|
Nov 28, 2017 03:59PM
|
|
Zenith AGM Presentation now posted on Zenith website
|
5
|
Zenith Epigenetics
|
Jan 15, 2016 08:18PM
|
|
Zenith AGM is October 5, 2016
|
4
|
Zenith Epigenetics
|
Aug 07, 2016 10:47PM
|
|
Zenith AGM Dec 15
|
1
|
Zenith Epigenetics
|
Oct 06, 2016 11:41PM
|
|
Zenith AGM Corporation Update Slides and Webcast
|
2
|
Zenith Epigenetics
|
Oct 31, 2019 09:01PM
|
|
Zenith abstract to be presented at AACR meeting 11/30
|
3
|
Zenith Epigenetics
|
Nov 18, 2016 12:44PM
|
|
Zenith Abstract at AACR 2017 Meeting April 1-5
|
4
|
Zenith Epigenetics
|
Mar 07, 2017 03:41PM
|
|
Zenith abstract at AACR
|
8
|
Resverlogix Corp.
|
Oct 26, 2015 10:57PM
|
|
ZEN003694 Trial Now Listed on ClinicalTrials.gov
|
5
|
Zenith Epigenetics
|
Mar 10, 2016 09:29AM
|
|
ZEN003694 Trial Now Listed on ClinicalTrials.gov
|
4
|
Resverlogix Corp.
|
Mar 10, 2016 09:33AM
|
|
ZEN003694 Trial Locations
|
4
|
Zenith Epigenetics
|
Apr 15, 2016 05:05PM
|
|
ZEN003694 Trial is now recruiting patients
|
3
|
Zenith Epigenetics
|
Apr 13, 2016 01:14PM
|
|
ZEN-3694/Enzalutamid... vs. Enzalutamide alone?
|
4
|
Zenith Epigenetics
|
Apr 05, 2018 05:39PM
|
|
ZEN-3694 the first pan-BET inhibitor in Phase 3?
|
5
|
Zenith Epigenetics
|
Oct 25, 2019 09:48AM
|
|
ZEN-3694 synergy with enzalutamide and PARP inhibitors
|
7
|
Zenith Epigenetics
|
Aug 09, 2019 11:19AM
|
|
ZEN-3694 Single Agent Trial Status
|
4
|
Zenith Epigenetics
|
Jul 14, 2017 01:49PM
|
